Beauty Packaging Staff01.04.21
L’Oréal has signed an agreement to acquire the Japanese company Takami Co., which develops and markets products licensed by the skincare brand Takami, owned by Doctor Hiroshi Takami, founder of two eponymous dermatological clinics in Tokyo.
L’Oréal also renewed a very long-term brand licensing agreement with Doctor Takami and signed a collaboration contract with the Takami clinics. According to L’Oréal, the acquisition should be completed in the next few weeks.
About Takami
The Takami brand, founded in 1999, is a premium skincare brand based on the know-how of the famous eponymous dermatological and aesthetic clinics established in the Omotesando district of Tokyo. The brand is particularly famous for its Skin Peel pre-serum, also called the "Little Blue Bottle" by Asian women.
Mainly available in Japan and in some Asian countries, notably in China where it enjoys strong appeal, the brand is marketed through an omnichannel distribution: mostly in e-commerce, in particular by subscription, as well as in selective distribution. The brand achieved sales revenue of about $61.2 million in 2019 and continues its growth this year despite difficult market conditions due to Covid-19 impacts.
Cyril Chapuy, president of L’Oréal Luxe, commented, “We are very pleased to welcome the Takami brand into our portfolio. Its reputation in Asia matches the remarkable quality of its products. Its expertise in prestigious beauty treatments and its omnichannel distribution make it a very complementary brand within L’Oréal Luxe."
Jérôme Bruhat, president of L'Oréal Japan, added, “The Takami brand teams led by Mr. Okamura have been able to build a strong reputation in skincare expertise, a unique visual identity and a core group of loyal customers in Japan. These are the pillars of the brand’s success that we will grow further in the future.”
“After 21 years of growth in Japan, we are thrilled to join the L’Oréal Group, the world’s leading beauty company, which will allow us to develop our brand thanks to its scientific and international expertise,” stated Yuji Okamura, president and owner of Takami Co.
L’Oréal also renewed a very long-term brand licensing agreement with Doctor Takami and signed a collaboration contract with the Takami clinics. According to L’Oréal, the acquisition should be completed in the next few weeks.
About Takami
The Takami brand, founded in 1999, is a premium skincare brand based on the know-how of the famous eponymous dermatological and aesthetic clinics established in the Omotesando district of Tokyo. The brand is particularly famous for its Skin Peel pre-serum, also called the "Little Blue Bottle" by Asian women.
Mainly available in Japan and in some Asian countries, notably in China where it enjoys strong appeal, the brand is marketed through an omnichannel distribution: mostly in e-commerce, in particular by subscription, as well as in selective distribution. The brand achieved sales revenue of about $61.2 million in 2019 and continues its growth this year despite difficult market conditions due to Covid-19 impacts.
Cyril Chapuy, president of L’Oréal Luxe, commented, “We are very pleased to welcome the Takami brand into our portfolio. Its reputation in Asia matches the remarkable quality of its products. Its expertise in prestigious beauty treatments and its omnichannel distribution make it a very complementary brand within L’Oréal Luxe."
Jérôme Bruhat, president of L'Oréal Japan, added, “The Takami brand teams led by Mr. Okamura have been able to build a strong reputation in skincare expertise, a unique visual identity and a core group of loyal customers in Japan. These are the pillars of the brand’s success that we will grow further in the future.”
“After 21 years of growth in Japan, we are thrilled to join the L’Oréal Group, the world’s leading beauty company, which will allow us to develop our brand thanks to its scientific and international expertise,” stated Yuji Okamura, president and owner of Takami Co.
